Short Interest in Nuwellis, Inc. (NASDAQ:NUWE) Declines By 14.3%

Nuwellis, Inc. (NASDAQ:NUWE) was the target of a large decrease in short interest in March. As of March 15th, there was short interest totalling 178,100 shares, a decrease of 14.3% from the February 28th total of 207,800 shares. Based on an average daily trading volume, of 481,900 shares, the days-to-cover ratio is presently 0.4 days. Approximately 4.1% of the shares of the company are short sold.

Institutional Investors Weigh In On Nuwellis

A hedge fund recently bought a new stake in Nuwellis stock. Geode Capital Management LLC bought a new stake in shares of Nuwellis, Inc. (NASDAQ:NUWE) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 30,806 shares of the company’s stock, valued at approximately $34,000. Geode Capital Management LLC owned 0.70% of Nuwellis at the end of the most recent quarter. 3.13% of the stock is currently owned by institutional investors.

Nuwellis Trading Up 2.8 %

NUWE traded up $0.03 during trading hours on Wednesday, hitting $0.99. The company’s stock had a trading volume of 4,747 shares, compared to its average volume of 995,554. Nuwellis has a fifty-two week low of $0.90 and a fifty-two week high of $14.35. The company has a 50-day simple moving average of $1.20 and a 200 day simple moving average of $1.32. The firm has a market capitalization of $4.31 million, a PE ratio of -0.01 and a beta of 0.36.

Nuwellis Company Profile

Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.